Register Now for The Outlook on Active Nutrition
News|Articles|March 24, 2026

PLT Health Solutions Launches Kinexa Joint Longevity Complex for Joint Structure and Mobility Support

Listen
0:00 / 0:00

Key Takeaways

  • Kinexa blends haritaki, turmeric, and boswellia as low-dose (200 mg/day) multi-extract approach positioned for joint structure, strength, and function rather than analgesia alone.
  • Trial design enrolled grade II–III OA adults 40–75, randomized double-blind placebo-controlled, with assessments at months 1, 2, 4, and 6.
SHOW MORE

The new clinically studied ingredient focuses on joint structure, cartilage health, and long-term mobility, reflecting growing demand for foundational joint health solutions in the supplement and functional ingredient markets.

PLT Health Solutions has announced the launch of a new joint health ingredient, Kinexa Joint Longevity Complex, a combination of standardized extracts of haritaki (Terminalia chebula), turmeric (Curcuma longa), and Indian frankincense (Boswellia serrata) designed to support joint structure, strength, and function while promoting long-term mobility.1 The company states that the ingredient is supported by a randomized, double-blind, placebo-controlled clinical study2 evaluating structural and functional joint health outcomes.

The launch reflects a broader shift in the joint health category toward structural support and long-term mobility rather than short-term comfort alone, which has historically been the focus of many joint health ingredients.

Clinical Study Evaluated Joint Structure and Function

According to the company, Kinexa was evaluated in a clinical study that assessed multiple aspects of joint health, including joint structure, cartilage composition, and functional mobility outcomes. Although still unpublished, It featured 100 participants ages 40-75 with either Grade II or III osteoarthritis. They were given 200 milligrams of Kinexa per day—or a placebo—for six months. Baseline assessments were made at the, 1, 2, 4, and 6-month marks.

The study examined the health and integrity of joint tissues such as cartilage, soft tissues, the synovial cavity, and underlying bone structures, in addition to traditional functional and subjective measures, such as WOMAC scores.

"To date, most clinical work in the joint health sector has focused on enhancing comfort,” explained Jeremy Appleton, ND, PLT Health Solutions’ director of medical & scientific affairs. “But joints aren't just ‘pain sensors.’ They are load-bearing mechanical systems. … Comfort is how the joint feels today; structure is what determines whether it keeps working years from now. Joint longevity is ultimately structural. When cartilage, meniscus, ligaments, and the foundation beneath the cartilage stay strong and resilient, the joint can absorb shock, distribute load evenly and remain stable through everyday life, training, aging, and wear-and-tear.”

Kinexa demonstrated improvements in joint structure and cartilage matrix composition, including cartilage thickness and shock-absorbing capacity. Some notable results include:

  • 24% improvement in knee strength
  • 10% improvement in cartilage thickness
  • 60% improvement in joint comfort
  • 49% decrease in joint stiffness

The study also evaluated joint stability and functional mobility outcomes, positioning the ingredient as a “whole joint” support solution rather than one focused solely on discomfort or inflammation.

Shift Toward Joint Longevity and Structural Health

Advanced imaging and structural assessments supported the clinical study, as many joint health studies in the supplement industry focus primarily on subjective measures such as pain, stiffness, or mobility rather than structural joint changes.

PLT positions Kinexa as addressing joint longevity by focusing on structural components such as cartilage, ligaments, meniscus, and the underlying bone that supports joint function.

Structural joint health is increasingly relevant for aging populations, active consumers, and preventative health approaches, where maintaining joint function and mobility over time is a key goal. This aligns with broader trends in the dietary supplement and functional ingredient markets toward healthy aging, mobility, and longevity-focused formulations.

Implications for the Joint Health Supplement Market

The launch of Kinexa comes at a time when joint health remains a competitive category in the dietary supplement industry. Ingredient innovation in this category has increasingly focused on clinically substantiated ingredients, low-dose actives, and multifunctional mobility solutions that support joint, muscle, cartilage, and bone health.

PLT Health Solutions has previously developed joint and mobility ingredients supported by clinical research, including ingredients targeting joint comfort, cartilage preservation, and mobility support. The company’s mobility platform includes ingredients addressing joint health, muscle health, and healthy aging, reflecting the growing convergence of mobility, longevity, and active aging product categories.

Clinically supported ingredients that demonstrate both structural and functional outcomes may offer opportunities for differentiated product positioning, particularly in the areas of healthy aging, sports nutrition, and mobility support.

Growing Demand for Mobility and Healthy Aging Ingredients

Mobility and joint health continue to be key focus areas for the nutrition industry, particularly as aging populations seek to maintain independence, activity levels, and quality of life. Ingredients that support long-term mobility and structural joint health may appeal to a broad range of consumers, including older adults, active lifestyle consumers, and preventative health users.

In recent years, the mobility category has expanded beyond joint comfort products into broader mobility solutions that include muscle health, bone health, cartilage support, and overall physical function. This shift reflects consumer interest in maintaining mobility across the lifespan rather than addressing joint discomfort only after it occurs.

As the joint health category continues to evolve, ingredients supported by clinical research demonstrating structural, functional, and mobility outcomes are likely to remain a focus for supplement manufacturers looking to differentiate products in a competitive market.

References

1. PLT Launches New Ingredient to Improve Joint Structure, Strength and Function, Promoting Long-Term Mobility. PR Newswire. Published March 23, 2026. Accessed March 24, 2026. https://www.prnewswire.com/news-releases/plt-launches-new-ingredient-to-improve-joint-structure-strength-and-function-promoting-long-term-mobility-302722066.html

2. Clinical Study Demonstrates Improved Musculoskeletal Structure for Stronger, More Resilient Joints. PLT Health Solutions. Accessed March 24, 2026. https://www.plthealth.com/resources/Clinical-Study-Demonstrates-Improved-Musculoskeletal-Structure-for-Stronger-More-Resilient-Joints